Security key
88322Q108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 105,421,180
- Total 13F value
- $3,501,169,700
- Share change
- +1,887,335
- Put/Call ratio
- 122%
- SEC-reported price per share
- $33.22
- Number of holders
- 364
- Value change
- +$72,878,388
- Number of buys
- 194
- Number of sells
- 154
- Shares outstanding
- 159,699,810
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
364
Top holders
10
TGTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
TG THERAPEUTICS, INC. SEC filings
TG THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88322Q108
Recent filing periods:
Ownership snapshot
Top reported holders of TGTX - TG THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
3/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 13%
12 rows are not safely comparable across share classes.
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 13%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 3
BlackRock, Inc.
13%
VANGUARD PORTFOLIO MANAGEMENT LLC
5.3%
STATE STREET CORP
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
13%
Reported 13D/G
· 31 Mar 2025
|
$883,115,925
20,134,882 shares
|
$0 | 31 Mar 2025 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
Vanguard Portfolio Management
|
5.3%
Reported 13D/G
· 31 Mar 2026
|
$279,054,976
8,400,210 shares
|
$0 | 31 Mar 2026 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
5.1%
Reported 13D/G
· 30 Sep 2025
|
$292,634,861
8,100,619 shares
|
+$24,085,260 | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$472,220,271
15,841,002 shares
|
— | 31 Dec 2025 |
| Michael S. Weiss |
3/4/5
CEO, Director
|
—
denominator unverified
|
$291,484,743
9,778,086 shares
|
— | 08 Jan 2026 |
| Clearbridge Investments, LLC |
13F
Company
|
—
denominator unverified
|
$102,785,853
3,448,033 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
364
Shares
105,421,180
Rows available
364
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
364
Q1 2026 holders
364
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend